Noul Co.,Ltd. (KOSDAQ:376930)

Market Cap	90.07B -9.4%
Revenue (ttm)	5.12B +219.8%
Net Income	-19.95B
EPS	-529.00
Shares Out	51.29M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	248,459
Average Volume	312,289
Open	1,770.00
Previous Close	1,739.00
Day's Range	1,689.00 - 1,770.00
52-Week Range	1,418.00 - 4,190.00
Beta	-0.33
RSI	59.01
Earnings Date	Apr 3, 2026

About Noul Co.,Ltd.

Noul Co.,Ltd. engages in the in-vitro diagnosis and remote diagnosis business worldwide. It offers miLab, an AI-based blood diagnostic medical device that automates sample preparation, imaging, and analysis. The company also provides malaria diagnostics, blood cell morphology analysis, cancer morphology, immunohistochemistry services, and digital cervical cell analysis solution. Noul Co.,Ltd. was incorporated in 2015 and is headquartered in Yongin-si, South Korea.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2015
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 376930

Financial Performance

In 2025, Noul Co.,Ltd.'s revenue was 5.12 billion, an increase of 219.83% compared to the previous year's 1.60 billion. Losses were -19.95 billion, -11.19% less than in 2024.